QIAGEN To Supply Molecular Screening Solutions To Increase Safety Of Blood Donations In Brazil
QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced that it has entered into an agreement to supply molecular sample and assay technologies for a new national, PCR-based blood screening program for HIV and Hepatitis C (HCV) in Brazil.
More: continued here
Filed under: HIV / AIDS on June 1st, 2009
You must be logged in to post a comment.